Literature DB >> 22449703

Identification of anti-HIV and anti-reverse transcriptase activity from Tetracera scandens.

Hyeok Sang Kwon1, Jung Ae Park, Joo-Hwan Kim, Ji Chang You.   

Abstract

We report here that an ethanol extract of Tetracera scandens, a Vietnamese medicinal plant, has anti-HIV activity and possesses strong inhibitory activity against HIV-1 reverse transcriptase (RTase). Using a MT-4 cell-based assay, we found that the T. scandens extract inhibited effectively HIV virus replication with an IC(50) value in the range of 2.0-2.5 μg/ml while the cellular toxicity value (CC50) was more than 40-50 μg/ml concentration, thus yielding a minimum specificity index of 20-fold. Moreover, the anti-HIV efficacy of the T. scandens extract was determined to be due, in part, to its potent inhibitory activity against HIV-1 RTase activity in vitro. The inhibitory activity against the RTase was further confirmed by probing viral cDNA production, an intermediate of viral reverse transcription, in virus-infected cells using quantitative DNA-PCR analysis. Thus, these results suggest that T. scandens can be a useful source for the isolation and development of new anti- HIV-1 inhibitor(s). [BMB reports 2012; 45(3): 165-170].

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22449703     DOI: 10.5483/BMBRep.2012.45.3.165

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  2 in total

1.  Identification of a novel type of small molecule inhibitor against HIV-1.

Authors:  Byung Soo Kim; Jung Ae Park; Min-Jung Kim; Seon Hee Kim; Kyung Lee Yu; Ji Chang You
Journal:  BMB Rep       Date:  2015-02       Impact factor: 4.778

2.  Dexamethasone induces the expression of LRRK2 and α-synuclein, two genes that when mutated cause Parkinson's disease in an autosomal dominant manner.

Authors:  Ji-Min Park; Dong-Hwan Ho; Hye Jin Yun; Hye-Jung Kim; Chan Hong Lee; Sung Woo Park; Young Hoon Kim; Ilhong Son; Wongi Seol
Journal:  BMB Rep       Date:  2013-09       Impact factor: 4.778

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.